BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 38712609)

  • 1. Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis.
    Sun L; Xu G; Liao W; Yang H; Xu H; Du S; Zhao H; Lu X; Sang X; Mao Y
    Oncotarget; 2017 Jun; 8(24):39658-39672. PubMed ID: 28487498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of peritumoral mast cells and T-regulatory cells predicts prognosis of hepatocellular carcinoma.
    Ju MJ; Qiu SJ; Gao Q; Fan J; Cai MY; Li YW; Tang ZY
    Cancer Sci; 2009 Jul; 100(7):1267-74. PubMed ID: 19432885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the dynamic transcriptional landscape of Treg subpopulations in pancreatic ductal adenocarcinoma: Insights from single-cell RNA sequencing analysis with a focus on CTLA4 and TIGIT.
    Miraki Feriz A; Khosrojerdi A; Erfanian N; Azarkar S; Sajjadi SM; Shojaei MJ; Vaferi MJ; Safarpour H; Racanelli V
    Immunobiology; 2024 Jun; 229(4):152822. PubMed ID: 38852289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of Tregs in development of hepatocellular carcinoma: a meta-analysis.
    Zhao HQ; Li WM; Lu ZQ; Yao YM
    World J Gastroenterol; 2014 Jun; 20(24):7971-8. PubMed ID: 24976734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment.
    Granito A; Muratori L; Lalanne C; Quarneti C; Ferri S; Guidi M; Lenzi M; Muratori P
    World J Gastroenterol; 2021 Jun; 27(22):2994-3009. PubMed ID: 34168403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
    Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
    Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells, especially ICOS
    Tu JF; Ding YH; Ying XH; Wu FZ; Zhou XM; Zhang DK; Zou H; Ji JS
    Sci Rep; 2016 Oct; 6():35056. PubMed ID: 27725696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
    Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
    J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
    Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
    Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.
    Zhou J; Ding T; Pan W; Zhu LY; Li L; Zheng L
    Int J Cancer; 2009 Oct; 125(7):1640-8. PubMed ID: 19569243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma.
    Vahidian F; Lamaze FC; Bouffard C; Coulombe F; Gagné A; Blais F; Tonneau M; Orain M; Routy B; Manem VSK; Joubert P
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398098
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition.
    van Eijs MJM; Verheijden RJ; van der Wees SA; Nierkens S; van Lindert ASR; Suijkerbuijk KPM; van Wijk F;
    Cancer Immunol Immunother; 2023 Dec; 72(12):4049-4064. PubMed ID: 37794264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic values of tissue-resident CD8
    Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
    World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.